GULFPORT, LA, UNITED STATES, March 11, 2026 /EINPresswire.com/ — Medication management for Attention Deficit Disorder (ADD) often involves two primary categories of ...
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, ...
This activity was supported by contracts between the National Academy of Sciences and Acadia Pharmaceuticals; Alzheimer’s Association; American Brain Coalition; American Neurological Association; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results